JP2014525395A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014525395A5 JP2014525395A5 JP2014524460A JP2014524460A JP2014525395A5 JP 2014525395 A5 JP2014525395 A5 JP 2014525395A5 JP 2014524460 A JP2014524460 A JP 2014524460A JP 2014524460 A JP2014524460 A JP 2014524460A JP 2014525395 A5 JP2014525395 A5 JP 2014525395A5
- Authority
- JP
- Japan
- Prior art keywords
- population
- antibody
- antibodies
- composition
- galactosylated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161521996P | 2011-08-10 | 2011-08-10 | |
| US61/521,996 | 2011-08-10 | ||
| US201161567364P | 2011-12-06 | 2011-12-06 | |
| US61/567,364 | 2011-12-06 | ||
| PCT/IB2012/001795 WO2013021279A2 (en) | 2011-08-10 | 2012-08-10 | Highly galactosylated antibodies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014525395A JP2014525395A (ja) | 2014-09-29 |
| JP2014525395A5 true JP2014525395A5 (https=) | 2015-10-01 |
| JP6433786B2 JP6433786B2 (ja) | 2018-12-05 |
Family
ID=47116104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014524460A Expired - Fee Related JP6433786B2 (ja) | 2011-08-10 | 2012-08-10 | 高度ガラクトシル化抗体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20140296490A1 (https=) |
| EP (1) | EP2741769B1 (https=) |
| JP (1) | JP6433786B2 (https=) |
| KR (1) | KR20140101331A (https=) |
| CN (1) | CN104168913A (https=) |
| BR (1) | BR112014003110A2 (https=) |
| CA (1) | CA2844435A1 (https=) |
| IL (1) | IL230719A0 (https=) |
| WO (1) | WO2013021279A2 (https=) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20140093603A (ko) | 2010-12-30 | 2014-07-28 | 라보라토이레 프란카이즈 듀 프락티온네먼트 에트 데스 바이오테크놀로지스 | 병원체 불활성화제로서의 글리콜 |
| EP2702077A2 (en) | 2011-04-27 | 2014-03-05 | AbbVie Inc. | Methods for controlling the galactosylation profile of recombinantly-expressed proteins |
| US9150645B2 (en) | 2012-04-20 | 2015-10-06 | Abbvie, Inc. | Cell culture methods to reduce acidic species |
| US9067990B2 (en) | 2013-03-14 | 2015-06-30 | Abbvie, Inc. | Protein purification using displacement chromatography |
| WO2013158273A1 (en) | 2012-04-20 | 2013-10-24 | Abbvie Inc. | Methods to modulate c-terminal lysine variant distribution |
| US9512214B2 (en) | 2012-09-02 | 2016-12-06 | Abbvie, Inc. | Methods to control protein heterogeneity |
| US10034921B2 (en) | 2013-02-13 | 2018-07-31 | Laboratoire Français Du Fractionnement Et Des Biotechnologies | Proteins with modified glycosylation and methods of production thereof |
| EP3594231A1 (en) | 2013-02-13 | 2020-01-15 | Laboratoire Français du Fractionnement et des Biotechnologies | Highly galactosylated anti-tnf-alpha antibodies and uses thereof |
| SG11201507230PA (en) | 2013-03-12 | 2015-10-29 | Abbvie Inc | Human antibodies that bind human tnf-alpha and methods of preparing the same |
| US9017687B1 (en) | 2013-10-18 | 2015-04-28 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same using displacement chromatography |
| US9217168B2 (en) | 2013-03-14 | 2015-12-22 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
| WO2014151878A2 (en) | 2013-03-14 | 2014-09-25 | Abbvie Inc. | Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides |
| MX384222B (es) | 2013-07-05 | 2025-03-14 | Lab Francais Du Fractionnement | Matriz de cromatografia de afinidad. |
| US9598667B2 (en) | 2013-10-04 | 2017-03-21 | Abbvie Inc. | Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins |
| US9085618B2 (en) | 2013-10-18 | 2015-07-21 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same |
| US9181337B2 (en) | 2013-10-18 | 2015-11-10 | Abbvie, Inc. | Modulated lysine variant species compositions and methods for producing and using the same |
| US20150139988A1 (en) | 2013-11-15 | 2015-05-21 | Abbvie, Inc. | Glycoengineered binding protein compositions |
| AU2015270152A1 (en) * | 2014-06-02 | 2016-12-08 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Production of Fc fragments |
| CN106687481B (zh) * | 2014-09-10 | 2022-03-22 | 豪夫迈·罗氏有限公司 | 半乳糖改造的免疫球蛋白1抗体 |
| FR3038517B1 (fr) | 2015-07-06 | 2020-02-28 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Utilisation de fragments fc modifies en immunotherapie |
| CN105277718B (zh) * | 2015-09-29 | 2018-03-20 | 上海知先生物科技有限公司 | 用于恶性肿瘤相关筛查及评估的产品、应用及方法 |
| EP3257866A1 (en) | 2016-06-17 | 2017-12-20 | Academisch Medisch Centrum | Modified anti-tnf antibody and use thereof in the treatment of ibd |
| EP3688194A1 (en) * | 2017-09-29 | 2020-08-05 | Oncgnostics GmbH | Risk determination for neoplasia and cancer |
| US11965032B1 (en) * | 2022-06-01 | 2024-04-23 | Tg Therapeutics, Inc. | Anti-CD20 antibody compositions |
| US11807689B1 (en) * | 2022-06-01 | 2023-11-07 | Tg Therapeutics, Inc. | Anti-CD20 antibody compositions |
| US11814439B1 (en) | 2022-06-01 | 2023-11-14 | Tg Therapeutics, Inc. | Anti-CD20 antibody compositions |
| US11884740B1 (en) | 2022-06-01 | 2024-01-30 | Tg Therapeutics, Inc. | Anti-CD20 antibody compositions |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US5175384A (en) | 1988-12-05 | 1992-12-29 | Genpharm International | Transgenic mice depleted in mature t-cells and methods for making transgenic mice |
| US6150584A (en) | 1990-01-12 | 2000-11-21 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| AU643141B2 (en) | 1991-03-15 | 1993-11-04 | Amgen, Inc. | Pulmonary administration of granulocyte colony stimulating factor |
| US5827690A (en) * | 1993-12-20 | 1998-10-27 | Genzyme Transgenics Corporatiion | Transgenic production of antibodies in milk |
| US5451569A (en) | 1994-04-19 | 1995-09-19 | Hong Kong University Of Science And Technology R & D Corporation Limited | Pulmonary drug delivery system |
| EP0690452A3 (en) | 1994-06-28 | 1999-01-07 | Advanced Micro Devices, Inc. | Electrically erasable memory and method of erasure |
| US5945577A (en) | 1997-01-10 | 1999-08-31 | University Of Massachusetts As Represented By Its Amherst Campus | Cloning using donor nuclei from proliferating somatic cells |
| CA2424977C (en) * | 2000-10-06 | 2008-03-18 | Kyowa Hakko Kogyo Co., Ltd. | Process for purifying antibody |
| NZ526720A (en) * | 2000-12-28 | 2007-11-30 | Altus Pharmaceuticals Inc | Crystallisation of whole antibodies or fragments thereof, on a large scale and a process allowing an alternative route for delivery of therapeutic antibodies |
| BR0316643A (pt) * | 2002-11-27 | 2005-10-11 | Gtc Biotherapeutics Inc | Anticorpos modificados estavelmente produzidos no leite e método de produzir os mesmos |
| FR2861080B1 (fr) * | 2003-10-20 | 2006-02-17 | Lab Francais Du Fractionnement | Anticorps presentant un taux de fucose et de galactose optimise |
| US20060127950A1 (en) | 2004-04-15 | 2006-06-15 | Massachusetts Institute Of Technology | Methods and products related to the improved analysis of carbohydrates |
| US20060057638A1 (en) | 2004-04-15 | 2006-03-16 | Massachusetts Institute Of Technology | Methods and products related to the improved analysis of carbohydrates |
| WO2006014683A2 (en) * | 2004-07-21 | 2006-02-09 | Glycofi, Inc. | Immunoglobulins comprising predominantly a gal2glcnac2man3glcnac2 glycoform |
| CA2583061C (en) * | 2004-10-06 | 2015-02-17 | Kwang Guan Tay | Antibody production method |
| DK1896071T3 (en) * | 2005-06-30 | 2015-05-26 | Janssen Biotech Inc | Methods and compositions with increased therapeutic activity |
| KR20080068089A (ko) * | 2005-10-21 | 2008-07-22 | 지티씨바이오쎄라퓨틱스,인크. | 항체 의존성 세포 독성 활성이 증강된 항체, 그 생산 및사용 방법 |
| CN101460522B (zh) * | 2006-04-11 | 2014-07-23 | 弗·哈夫曼-拉罗切有限公司 | 糖基化抗体 |
| US7846724B2 (en) * | 2006-04-11 | 2010-12-07 | Hoffmann-La Roche Inc. | Method for selecting CHO cell for production of glycosylated antibodies |
| SI2073842T1 (sl) * | 2006-09-10 | 2015-05-29 | Glycotope Gmbh | Uporaba človeških celic izvirajočih iz mieloične levkemije za izražanje protiteles |
| CN101588817B (zh) * | 2006-09-10 | 2013-06-12 | 葛莱高托普有限公司 | 骨髓白血病来源的细胞在抗体表达中的用途 |
| EP1985633A1 (en) * | 2007-04-26 | 2008-10-29 | LFB Biotechnologies | Kit of parts for the treatment of cancer or infectious diseases |
-
2012
- 2012-08-10 WO PCT/IB2012/001795 patent/WO2013021279A2/en not_active Ceased
- 2012-08-10 US US14/237,751 patent/US20140296490A1/en not_active Abandoned
- 2012-08-10 KR KR1020147005724A patent/KR20140101331A/ko not_active Ceased
- 2012-08-10 EP EP12780530.7A patent/EP2741769B1/en not_active Not-in-force
- 2012-08-10 JP JP2014524460A patent/JP6433786B2/ja not_active Expired - Fee Related
- 2012-08-10 CA CA2844435A patent/CA2844435A1/en not_active Abandoned
- 2012-08-10 CN CN201280049783.1A patent/CN104168913A/zh active Pending
- 2012-08-10 BR BR112014003110A patent/BR112014003110A2/pt not_active IP Right Cessation
-
2014
- 2014-01-29 IL IL230719A patent/IL230719A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014525395A5 (https=) | ||
| PH12020550039A1 (en) | Sialyltransferases and their use in producing sialylated oligosaccharides | |
| SA520411173B1 (ar) | Pd-l1 عوامل ربط ترتبط بـ واستخدامها cd137 | |
| MY176822A (en) | Anti-pd-1 antibody and use thereof | |
| AU2012259312A8 (en) | Blockade of tl1a-dr3 interactions to ameliorate t cell mediated disease pathology and antibodies thereof | |
| WO2014125374A3 (en) | Highly galactosylated anti-tnf-alpha antibodies and uses thereof | |
| WO2013049227A3 (en) | High efficiency, small volume nucleic acid synthesis | |
| EP4282881A3 (en) | Antibodies against csf-1r | |
| EP4303232A3 (en) | Chimeric antigen receptor and methods of use thereof | |
| WO2016091268A3 (en) | N-glycosylation | |
| WO2012049083A3 (en) | Novel fucosyltransferases and their applications | |
| WO2014153188A3 (en) | High efficiency, small volume nucleic acid synthesis | |
| MX346518B (es) | Metodos de desarrollo de variantes de terpeno sintasa. | |
| AR083114A1 (es) | Produccion de anticuerpos de fucosa baja en celulas de rata h4-ii-e | |
| WO2012016227A3 (en) | Antibodies with modified isoelectric points | |
| WO2011150241A3 (en) | Decreasing lactate level and increasing polypeptide production by downregulating ldh and pdhk expression | |
| WO2011123708A3 (en) | Genetic engineering of non-human animals for the production of chimeric antibodies | |
| EA201591131A1 (ru) | Днк-конструкции антитела и способ их применения | |
| JP2011525355A5 (https=) | ||
| TN2011000524A1 (en) | Antibodies specific to cadherin -17 | |
| WO2012009544A3 (en) | Domain insertion immunoglobulin | |
| MX2015011781A (es) | Medio de cultivo celular y metodos de produccion de anticuerpos. | |
| MY150559A (en) | New core shell particle multistage polymer powder, its manufacturing process and composition comprising it | |
| MX2014001245A (es) | Metodo para producir un copolimero en bloque. | |
| WO2014125377A3 (en) | Highly galactosylated anti-her2 antibodies and uses thereof |